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Abstract. The influence of periodontal therapy on serum antibody titers to selected
periodontal disease-associated microorganisms was assessed in 23 patients
having chronic inflammatory periodontal disease (CIPD). The immunoglobulin
G (IgG) titers were determined by the microELISA technique in serum samples
obtained prior to treatment; following a hygienic phase which included scaling,
root planing, and oral hygiene instruction; following surgical treatment; and one
year and two years following hygienic phase (maintenance phase). Considerable
individual variability existed in the magnitude of immune response to specific
bacterial preparations. Significant reductions in the mean antibody titers were
seen to A. vi.scosus, S. .sanguis. F. nucleatum, S. sputigena. B. gingivalis. B. t'nterme-
dius. B. melaninogenicm, T. vincentii, and T denticola by the end of the second
year of maintenance. There was no consistent response to Capnocvtophaga. When
individual patient responses were examined. 6 of the 23 were found to have
elevated titers to at least one of the microorganisms in the interval between
pretreatment and the end of the hygienic phase; however, in all but one case, the
titers at the end of the second year of maintenance were below pretreatment levels.
Antibody levels to bacteria such as 5". sanguis were modified during therapy. Tliis
would indicate that immune responses to microbes not generally considered to be
"periodontal pathogens" may be modified by adjuvant activity associated with
subgingival plaque or changes in the environment of the sulcus and that sub-
sequent changes in titer do not necessarily rellect a role of that microorganism
in the disease process.
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The host immunologic response to the
microbial flora of the ora! cavity has
been studied extensively for a potential
role in the etiology of chronic inflamma-
tory periodontat disease (CtPD) (Baker
et al. 1976, Baker et al. 197S, Genco
et al. 1974, Ivanyi et al. 1972, Page &
Schroeder 1982). While its actual role
in the disease is still unclear, the host
response provides a sensitive indicator
of the flora that inhabils the oral cavity,
especially the microorganisms that re-
side in the gingivai sulcus (Tew et al.
1985a, b, Vandesteen et al. 1984. Willi-
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ams et al. 1985). Recently, cross-sec-
tional studies have indicated that levels
of certain microbial species are elevated
during certain stages of CIPD and that
[he titers of serum and gingivai crevicul-
ar fluid antibodies to these microbes are
also elevated (Ebersole et al. 1986. Hof-
stad 1984, Naito et al. 1985, Tew et al.
1985a, b). Other studies have shown
that antibodies to many of these species
appear normally in the sera during
maturation from the neonate to the
adolescent (Mouton et al. 1981). Thus,
••preinfection" sera do not usually exist
and "normal" antibody titers to these
microorganisms vary considerably. As a
result, one must examine relative
changes in levels of antibodies when
comparing states of health and disea.se.
An assessment of the success of a par-
ticular stage of periodontal therapy is
difficult because it is cumbersome to
routinely monitor patients for the pres-
ence of periodontal disease associated
fiora. Monitoring the flora by assessing
the host response to it may provide a
simpie means of assessing patient status
during maintenance phase of therapy.
We report the results of a longitudinal
study on the effects of periodontal ther-




Sera were obtained from 23 patients
participating in an ongoing longitudinal
clinical trial at The University of Michi-
gan School of Dentistry (Hill et al.
1981). There were nine males and four-
teen females in the age range 24-60
years. To be selected for the study, each
patient had to fulfill the following cri-
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teria; (1) have at least one periodontal
pocket extending 4 mm or more apically
to the cement-enamel junction, and (2)
have at least twenty treatable teeth. Pa-
tients with poor systemic health and
those in need of extensive restorative
dentistry were excluded from the study.
Clinical procedures
Clinica! examinations were performed
prior to treatment and foilowing differ-
ent stages in therapy. The clinical par-
ameters employed were Plaque Index
(Silness & Loe 1964) gingival health ac-
cording to the criteria of the Periodontal
Disease Index (Ramijord 1959), and
pocket depth and attachmetit level in
relation lo the cement-enamel junction
(Ramfjord 1967). AtYer the pretreat-
ment examination (PT) the hygienic
phase (PH) protocol was performed.
This included scahng, root planing and
oral hygiene instruction for all patients.
Approximately 4-6 appointments over
a period of one month (total of 5-8 h)
were required to complete the hygienic
phase for each subject. All initial
measurements were repeated for each
subject 4 weeks after the completion of
the hygienic phase. Following the tatter,
a periodontist performed surgery or sca-
ling and root planing under local anes-
thesia in each patient. The details of
Vhe surgical and nonsurgical therapeutic
procedures have been described else-
where (Hill et al. 1981). At the com-
pletion of the surgical phase, patients
were placed on a three month mainten-
ance prophylaxis recall. Patients were
rescored annually from the post-hy-
gienic phase evaluation prior to the re-
call prophylaxis. Clinical parameters
were assessed at pretreatment (PT),
post-hygienic phase (PH), post-surgical
phase (PS. 4 weeks after the removal of
the last surgical dressing), maintenance
phase 1 (MPl. one year after the end of
the hygienic phase), and tnaintenance
phase II (MP2, two years after the end
of the hygienic phase). Whenever tbe
clinical parameters were assessed, 50 ml
of peripheral blood were obtained from
each patient. Resultant sera were stored
frozen at — 7O'C until used.
Antigen preparation
Isolates of the following microorgan-
isms were used: Actinomvces viseosus
(AV), Streptococcus .sanguis (SS), Fusa-
baciermm nucleatum (FN), Selenomonas
sputigena (SEL), Bacteroides gingivalis
(BG), Bacteroides intermedius (BI). Bac-
teroides melaninogenicus (BM). Capno-
cytophaga sp. (.CAP), Treponema vincen-
(ii (TV) and Treponema denticola (TD).
Unless otherwise noted, these isolates
were obtained from sites of naturally
occurring gingivitis or periodontitis dur-
ing previous clinical studies. Cultural
methods for isolation and characteriz-
ation have been described elsewhere
(Loesche et al. 1981. Mangan et al.
1982). The cultures Were grown in 500
ml batches and harvested by centrifuga-
tion at 12,000 g for 30 minutes. The cell
pellets were washed in sterile phosphate
buffered saline (PBS. 0.05 m PO4, 0.15
M NaCl, pH 7.4) and suspended in ster-
ile distilled water to give a fmal concen-
tration of 20 mg (wet weight) per miUili-
ter. The washed cells were subjected to
a total of thirty minutes of ultrasonic
disruption, (model W185D, Heat Sys-
tems Ultrasonics, Inc.. Plainview. New
York) delivered in five minute intervals
with alternate periods of cooling in an
ice bath. The ultrasonicates were centri-
fuged at 12.000 g for 30 min and the
supernatant fraction lyophilized.
Measurement of serum antibody titers
Ultrasonicate preparations of oral
microorganisms were diluted (.5 //g/ml)
in sodium carbonate coating buffer (pH
9.6, containing O.OIVo NaN^) and then
0,20 ml was added to the wells of round
bottom microtiter plates (Immulon, Dy-
natek Laboratories, Inc., Alexandria,
VA). This concentration was previously
determined to result in optimal sensiti-
zation for the microorganisms tested.
The plates were then sealed with cello-
phane tape and incubated at room tem-
perature (22-24'O overnight in a
closed chamber with high humidity. The
following morning, the plates were
washed with PBS containing polyoxye-
thylene(20)sorbitan (Tween 20'"'. Ma-
theson, Coleman and Bel), Norwood.
OH) (PBS-T).
Serutn san:iples were serially diluted
in PBS-T (beginning at 1/40). To assure
consistency, al) samples of a single pa-
tient were always analyzed in the same
plate. The serutn dilutions were added
to the sensitized wed (0.20 ml/well). In
addition, a reference serum, prepared
by pooling 20 individual serum samples
from healthy donors having no perio-
dontal disease (equal number of males
and females, ages 20 to 50 years) was
diluted in a similar fashion and added
to a row of wells in each plate. This
reference serum served as an internal
standard with which to contro! for the
development of the ELISA and for sub-
sequent calculations of ELISA Units
(see below). After a three hour incu-
bation peTiod at room temperature, the
plates were washed five times in PBS-
T. Alkaline phosphatase (calf intestine,
type VIL Sigma Chemical Co.. St.
Louis. MO) was conjugated to heavy
chain-specific rabbit anti-human immu-
noglobulin G CgG) Bio-Rad Labora-
tories. Richmond, VA.) by glutaralde-
hyde treatment. The conjugate was di-
luted in PBS-T (1:2000: previously
determined to be optimal) and 0.20 ml
was added to each well. Following an
overnight incubation at room tempera-
lure, the plates were again washed 5
times in PBS-T. Alkaline phosphatase
substrate (Sigma 104'̂ '̂ . Sigma Chemi-
cal Co., St. Louis. MO, I mg/nil in 0.05
M NaCO, and 1 mM MgCl;, pH 9,8)
was added to each welt (0,20 ml/well).
After fifteen minutes, the reaction was
stopped with 0.025 ml of 6N sodium
hydroxide. The absorbancy (405 nm) of
each well was then determined (Titertek
Multiskan. Flow Laboratories. McLe-
an, VA). Antibody activity in the sera
was expressed as ELTSA units (EU).
This value was defined by a linear re-
gression analysis of the reference serum
titration, EU of all the samples were
calculated b^ relating optical density
values from each experimental sample
to the reference serum, which was assig-
ned a value of 100 EU (Naito 1984),
Only absorbance values occurring in the
linear portion of the titraiion curves
were used.
Statistical analysis
The significance of the changes in the
antibody titers at successive timepoints
were assessed by paired r-tests. Cross-
correlation coefficients were computed
to see whether or not the patterns of
change of the various titers were similar
within each of the patients (Kowalski &
Guire 1974),
Results
Changes in clinical parameters duDng
therapy
The clinical status of these patients and
their response to treatment has been
previously reported (Lopatin et al.
1983). Briefly, a significant reduction in
dental plaque (plaque index) and gin-
gival inflammation (gingival index) was
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Figs. 1. 2. Longitudinal changes in antibacterial antibody titer following periodontal therapy. Each panel shows the mean ELISA unit values
( + S.E.M.) calculated for the indicated microorganism at five time points during the treatment protoeol. Intervals: A. Pretreatment, B. Post
hygienic phase. C Post surgical phase. D. Maintenance phase-firsl year, E. Maintenance phase-second year. Cross-hatched line indicates
healtUy pooled sera reference value (100 ELISA units).
observed at all examinations in the pa-
tients group foUowing the hygienic
phase. In addition, there was a decrease
in probing depth in the 4^6 mm and >
7 mm sites over the two years post surgi-
cal phase and maintenance of level of
attachment in all sites during the same
time period.
Changes In antibody titers during therapy
As shown in Figs. I. 2. with the excep-
tion of Capriocviophaga. periodontal
therapy pvoduced a reduction in the
mean antibacterial antibody titers,
which was significant (/7<O.O5}. when
the pretreatment (PT) measurements
were compared to those of the 2-year
post surgical phase (MP2}, Since all of
the antibody titrations were compared
to a reference serum pool (arbitrarily
defined as possessing a titev of 100 EU).
obtained from an age-matched group of
healthy individuals who had no evi-
dence of inflammatory periodontal dis-
ease, the humoral responses of the pa-
tients to these microorganisms could be
clearly categorized by whether a de-
crease in titer occurred from a supranor-
mal value, i.e.. the pretreattrient ELISA
titer was significantly in excess of 100
EU. or whether the periodontal therapy
caused a decrease from a relatively nor-
mal value, i.e., pretreatment titer less
l-han or equal to 100 EU. As shown in
Figs. 1, 2. the mean antibody titers to 4
oral microorganisms were clearly elev-
ated over normal control values {indi-
cated by cross-hatched bars at 100 EU).
These included B. gingivalis (BG, 260
EU), 5. sputtgena (SS. 175 EU). A. vi-
seosus (AV. 240 EU), and fi. intermedius
(BI. 140). There were significant
(/j<0,05) reductions in the mean anti-
body titers to the remaining microor-
ganisms, however, those changes were
all relative to the values one would ex-
pect to fmd in healthy, non-perio-
dontally diseased control subjects.
The intervals during which the de-
creases in antibody titers occurred were
not the same for each microorganism.
Table 1 indicates the % changes in the
antibody titers (and significance of the
changes) between each treatment inter-
val. In the interval between PT and PH.
there is a significanl reduction in the
titer to SS (8.7%. /?<0.003), BG
(13.5%. p^O.Ol), and BM (10.7%,
;)<0.02). In the interval between PH
and PS, there was another significant
decrease in the titer to BG (12.4%,
;»<0.02). In no case was there a signifi-
cant change in the antibody titer be-
tween PS and MPl. In the final interval
examined, MPl to MP2, decreases in
the mean titers occurred with all of the
microorganisms tested, however, only
those decreases associated with AV
(12.8%,/j<0.03),FN (15.4%./7< 0.02),
SEL (18.1%. /j<0.01). and TV (13.9%.
;?<0.02) were significant. In general, a
change in the mean antibody titer less
than 8% did not appear to be statisti-
cally significant.
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* % decrease in ELISA Units. P-valui; indicated by parentheses. Boxed va\ue indicates a signil'icanl change with Bonferronl correction a
(p<0.05).
Abbreviations: PT, pretreatmeni; PH, post-hygienic phase; PS. post-surgical phase; MPl , maintenance phase h t year; MP2. mainti
phase 2nd year.
ippVied
We might remark that since teveral
tests were performed in Table 1 for each
microorganism, viz., one for each pair
of successive timepoints for a total of
five tests, some investigators might sug-
gest the Bonferroni's approach (Glantz
1981) to "correct" the individual F-
values to ones more appropriate for the
situation in which multiple, related tests
are perfotmed. This correction amounts
to multiplying each of the P-values
shown in Table 1 by 5 (the number of
tests performed). Thus, the only con-
trasts shown to be significant are those
for which the uncorrected P-values are
If results of individual patients are
examined, however, a sJightly different
picture of the change in the humoral
immune response to these microorgan-
isms was seen. While it is difficult to
present such individual results in simple
tabular form, lieveral obsevvations can
be made. There was no unique pattern
of humoral responses following treat-
ment. Attempts to demonstrate re-
lationships between antibody responses
to different microorganisms did not re-
veal typical patterns. Wirh the exception
of one patient, the trend was a general
reduction in antibody titers with treat-
Fig. 3. Changes in humoral antibody titers
during therapy to selected oraj microorgaH-
isms in patient no. 10. Patient no. 10 repre-
sented a unique pattern of humoral immune
response during periodontal therapy.
ment. In this patient and 5 others, there
were increases in antibody titers to se-
lected microorganisms immediately fol-
lowing the hygienic phase. In most
cases, these increases represented a re-
sponse to a single microorganism and
this early increase was not predictive of
the ultimate antibody titer at the end of
two years. The responses of patient no.
10 are shown in Fig, 3. This individual's
response to therapy was unique in this
group, since although a modest increase
in titer was found to occur in five other
patients (for 1-2 bacteria), which by
MP2 was decreased below pretreatment
levels in three subjects, this patient dem-
onstrated significantly elevated anti-
body titers to six of the ten bacteria,
and he did not ultimately demonstrate
a significant decrease in titer over the
entire course of treatment to any bac-
teria. The case history and response to
Vherapy of this patient was unremark-
able when compared to the other pa-
tients in this study.
Discussion
Numerous studies have attempted to
correlate patient systemic immunity to
specific oral microorganisms with the
severity of inflammatory periodontal
disease (Baker et al. 1976, Baker et al,
1978. Genco et al. 1974, Ivanyi et al.
1972, Page & Schroeder 1982).
Lymphocyte blastogenic responses to
disease-associated microorganisms have
been examined in longitudinal studies
(Lopatin et al. 1983. Osterberg et al.
1983), however, their value in predicting
or establishing the severity of disease is
questionable.
The humoral immune response has
also been studied for its ability to corre-
late with disease activity. High corre-
lations beiween antibody titers and dis-
ease activity has been demonstrated for
selected microorganisms in cross-sec-
tional studies. For example, there is a
particularly high degree of association
between the presence of antibodies to
Ac/ifiohacHlux actlnomvceivtrtcomilans
and the occurrence of localized juvenile
peTiodoniiiis (Ebersole et al. 1982). In
contrast, patients with adult or with
rapidly progressive periodontitis fre-
quently have increased levels of IgG
antibodies to Bacteroides gingivalis
(Mouton etal. 1981).
However, the predictive value of
single time point antibody measure-
ments in assessing disease, or its utility
in assessing treatment is not clear be-
cause, even with a high correlation be-
tween disease severity and antibody ti-
ter, numerous subjects possess antibody
titers that fall above and below the
ranges that identify health and disease,
irrespective of their oral health status.
This situation is 6MS. to fact that most of
the members of the oral flora associated
with chronic inflammatory periodontal
disease states can be identified in
healthy subjects (Loesche & Syed 1978,
Loesche et al. 1985), and that antibody
titers to this flora appears in adoles-
cence (Mouton et al. 1981) and can be
demonstrated in health (Doty et al.
1982).
Since it is virtually impossible to ob-
tain pre-disease sera from individuals
who have developed CIPD, normal
baseline antibody levels lo the oral flora
are not tisually available. We therefore
measured the antibody levels to a select
group of oral microorganisms in a
longitudinal fashion in order to assess
treatment effects. Presumably, a return
to health would result in a reduction
of the oral immune sensitixation to the
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periodontal disease associated microor-
ganisms.
The results suggest that scaling and
root planing result in general reduction
of antibody titers to the oral microor-
ganisms, in many cases to levels below
those of normal subjects. The humoral
response appears to be elevated to sus-
pected periodontal "pathogens" such as
BG, as well as "innocuous" oral flora
such as SS, suggesting that there is a
general sensitization to most of the flo-
ra. 2 characteristic types of responses
were observed (Table 1). First, signifi-
cant early (PT-PH) decreases in anti-
body titers were associated with BG, SS,
and BM. Second, progressive, cumula-
tive changes that resulted in a significant
decrease in titers by the end of the main-
tenance phase (MP2) were seen with the
remaining microorganisms, with the ex-
ception of CAP In this table. CAP is the
sole species not resulting in a significant
mean group change in response to treat-
ment. CAP titers were found to be the
most variable in response to treatment.
Presumably, the changes in antibody
titers seen during this study resuh from
reductions in the numbers of specific
members of the microflora. Microbio-
logical studies (reviewed by Page & Sch-
roeder 1982) describe the presence of
high levels of BG in untreated lesions
oi adult periodontitis. Although the
microbiota of the gingival sulcus was
not monitored in this study, the pro-
gressive decrease in antibody titers to
BG and other CIPD-associated micro-
organisms probably reflects reductions
in levels of these microorganisms during
therapy,
A recent report (Ebersole et al. 1985)
also examined the humoral immune re-
sponse to seiected oral microorganisms
foilowing therapy. In their study, pa-
tients treated with scaling and root plan-
ing demonstrated increased antibody ti-
ters to certain microorganisms, while
their responses rarely decreased below
pretreatment values within the timefra-
me examined. Their findings were ex-
plained as a re-immunization to the oral
flora resulting from the trauma of the
treatment protocol. Since the sampling
intervals and methods of therapy dif-
fered significantly between our study
and theirs, it is difficult to make a com-
parison between the results. However.
a comparison between the studies does
suggest that the antibody levels are
quite sensitive to the therapy. In our
study, six patients demonstrated an in-
crease in antibody titer to selected
plaque microorganisms during the PT-
PH phase of treatment. Since the mode
of therapy might be expected to result
in a certain level of additional sensitiza-
tion, and bacteremias have been shown
to accompany such procedures (Hock-
ett et al. 1977), increasing levels of anti-
bodies to the oral fiora would not be
unexpected. However, three of the six
patients ultimately demonstrated re-
duced antibody titers by the end of the
second maintenance phase. It is not
clear at present what is unique about the
remaining patients, especially patient 10
who demonstrated increased titers to six
out of ten of the bacteria. Their (clin-
ical) response to therapy did not differ
from that of the other patients.
Our findings do not shed light on the
role of the periodontal disease associ-
ated microorganisms in the etiology of
CIPD. In fact, since antibody levels to
bacteria such as S. sanguis were also
modified during therapy, one must con-
sider the possibility that immune re-
sponses to microbes not generally con-
sidered to be "periodontai pathogens"
are modified by adjuvant associated
with subgingival plaque. Alternatively,
the levels of these "non-pathogens" in
the sulcus may be influenced by the en-
vironment created by the "pathogen".
Thus, changes in antibody titers to a
microbiai antigen preparation would
not necessarily identify a role for that
microorganism in the disease etiology.
The results of this study, however, tend
to support the concept that periodontal
treatment reduces the antigenic stimuli
in the periodontium. resulting in de-
creased antibody titers to the plaque flo-
ra, in general. In many cases, the anti-
bacterial titers were quite resistant to
change, and the time elapsed between
initiation of therapy and occurrence of
significant changes in antibody levei ex-
ceeded one year. This was also sug-
gested by observations in edentulous
subjects where the length of time the
individuals were totally edentulous has
a significant influence upon the levels of
circulating antibodies to oral microor-
ganisms (Jacob et al. 1982). One might
expect that once sensitized to a particu-
lar antigen, maintenance of that im-
mune response would require minimal
levels of antigen in the gingival sulcus,
because of the sensitivity of the anamne-
stic response. As a result, those re-
sponses which are most easily eradi-
cated might be thought to be to bacteria
that were most easily eliminated or
which are the poorest immunogens. The
more persistent immune responses
might, thus, be considered to be associ-
ated with more difficult to eliminate flo-
ra, or those associated with health. The
most significant use of this type of
analysis might be the monitoring of the
maintenance patient who has demon-
strated reduced antibody titers as a re-
sult of therapy. In a patient primed im-
munologically to the CTPD-associated
microorganisms, one might expect a
very rapid rise in the antibody titer if
the crevicular fiora increases, possibly
suggesting that additional therapy is de-
sirable. One cannot overstate, however.
that because of individual variability in
the magnitude of immune responses to
specific bacterial preparations, pretreat-
ment sera from each patient must serve
as that individual's baseline reference.
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Zusammenfassung
Die Auswirkung parodontaler Therapie auf die
Serum Aniikorper (IgG) - Niveatis von
Plaq ue-Mikro organ ismen
Der EinfluB parodontaler Therapie aut" die
Scrum-Anti korpcriiler von selckticrten, mit
der Krankheit assoziierten parodontalen Mi-
kroorganismen. wurde bei 23 Palienten mil
chronisch entzlindlicher Parodontalkrank-
heit (CIPD) beurleilt. In Serum-Stichproben
wurde der Immunoglobulin G (IgG)-Titer
mit der Mikro-ELISA-Technik vor der Be-
handlung beslimmt und zwar nach der Hy-
gienephase mit Zahnsteinentfernung, Wurzel-
glattung und Instruktion in oralcr Hygiene;
nach der chirurgischen Behandlung. sowie 1
Jahr und 2 Jahre nach der Hygienephase
(Nachsorgephase). Die Immunantworten ge-
geniiber speziellen bakteriellen Zubercitun-
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gen schwankten betrachtlich. Gegeniiber A.
viscosu,^, S. sanguis. F. nucleatum, S. sputigena
und B. gingivalis, sowie B. intermedius, B.
metaninogenicus, T, vincentii und T. denticota
wurden gegen Ende des 2. Nachsorgejahres
signifikanle Reduktionen der mittJereii Anti-
korpcr-Titer beobachtet. Auf Capnocytopha-
ga kam es zu keiner gleichbleibenden Niveau-
Antwort. Bei naherer Untersuchung der Ant-
worteii der einzelnen Palienten zeigle es sich.
daB bei 6 Patienten in der Zeit zwischen Vor-
behandlung und dem Ende der Hygienephase
ein erhohter Titer gegen zumindest einen der
Mikroorganismen vorlag. Mit einer Ausnah-
me lagen jedoch in alien Fallen die Titer ge-
gen Ende des 2. Nachsorgejahres unterhalb
der Niveaus, die vor der Behandlung konsta-
tiert worden waren. Antikorpemiveaus ge-
genuber Bakterien wie S. sanguis iinderten
sich wahrend der Behandlung. Das konnte
bedeuten, daB Immunantworten auf Kleinst-
lebewesen. die generell nicht als "parodontale
Pathogene" angesprochen werden, dureh
StiilzmaBnahmen hinsichtlieh der subgingi-
valen Plaque oder durch Veranderungen des
Sulkus-Milieus modifiziert werden konnen
und daB die dann zu beobachtende Verande-
rung des Titers nieht unbedingt die Rolle wi-
dergibt. die dieser Mikroorganismus in dem
Krankheitsprozess spielt.
Resume
Effets du traitement parodontat sur les taux
d'anticorps seriques (IgGj aux microrganis-
mes de la ptaque
L'influence du traitement parodontai sur les
taux d'anticoprs seriques a certains microrga-
nismes associes a la maladie parodontale a
ete determinee chez 23 patients souffrant de
parodontite chronique. Les taux d'IgG ont
ete determines par la technique microELISA
d'echantilions de serum obtenus avant le trai-
tement, apres une phase d'hygiene (detartra-
ge, lissage radiculaire et instruction en hygie-
ns buccale). apres la chirurgie parodontale
ainsi qu'une et deux annees apres la phase de
maintien. Une variatioh individuelle conside-
rable existait dans I'ampleur des reponses im-
munitaires aux preparations baeteriennes
specifiques. Des reductions significatives
dans les taux d'anticorps moyens ont ete no-
e'es pour t'A. viseosus, le S. sanguis, ie F.
nucteatum, le S. sputigena, le B. gingivatis. le
B, intermedius, le B. metaninogenicus, le T.
vincentii et le T. denticota a la fin de la seconde
annee de maintien. 11 n'y avait aucune repon-
se coherente au Capnocytophaga, Lorsque les
reponses individuelles des patients etaient ex-
aminees, six des 23 sujets possedaient des
taux eleves a au moins un des microrganis-
mes, dans I'intervalie enlre le pre-lraitement
et la fin de la phase d'hygiene; cependant,
dans tous les cas sauf un, les taux a la fin
de la seconde annee de maintien etaient en
dessous des taux pre-traitement. Des taux
d'anticorps aux baeteries teiies que !e S. san-
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cessairement un role de ce microrganisme
dans tc processus de la maladie.
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